Glenbrook Capital Management Acquires 8,000 Shares of Senestech (NASDAQ:SNES) Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 8,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were bought at an average cost of $1.73 per share, for a total transaction of $13,840.00. Following the acquisition, the insider owned 610,354 shares in the company, valued at approximately $1,055,912.42. The trade was a 1.33% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, February 13th, Glenbrook Capital Management acquired 15,390 shares of Senestech stock. The shares were bought at an average cost of $1.89 per share, with a total value of $29,087.10.
• On Thursday, February 12th, Glenbrook Capital Management bought 7,956 shares of Senestech stock. The stock was bought at an average price of $1.72 per share, for a total transaction of $13,684.32.
• On Thursday, February 5th, Glenbrook Capital Management bought 2,884 shares of Senestech stock. The stock was bought at an average cost of $1.77 per share, with a total value of $5,104.68.
• On Wednesday, February 4th, Glenbrook Capital Management bought 5,685 shares of Senestech stock. The shares were bought at an average price of $1.82 per share, with a total value of $10,346.70.
• On Monday, February 2nd, Glenbrook Capital Management purchased 42,739 shares of Senestech stock. The shares were purchased at an average cost of $1.98 per share, for a total transaction of $84,623.22.
• On Friday, January 30th, Glenbrook Capital Management acquired 5,399 shares of Senestech stock. The stock was purchased at an average cost of $1.87 per share, with a total value of $10,096.13.

Senestech Stock Up 12.4%

Senestech stock opened at $2.00 on Friday. Senestech, Inc. has a one year low of $1.30 and a one year high of $6.24. The stock has a fifty day moving average of $2.17 and a 200 day moving average of $3.41. The company has a debt-to-equity ratio of 0.01, a quick ratio of 14.73 and a current ratio of 15.75. The stock has a market cap of $10.45 million, a PE ratio of -0.55 and a beta of 0.21.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold”.

Hedge Funds Weigh In On Senestech

Several large investors have recently added to or reduced their stakes in SNES. Jane Street Group LLC purchased a new stake in shares of Senestech in the fourth quarter worth $32,000. Diversify Advisory Services LLC bought a new position in Senestech in the 4th quarter worth $34,000. Geode Capital Management LLC purchased a new stake in Senestech in the 2nd quarter worth $59,000. Essex Investment Management Co. LLC purchased a new stake in Senestech in the 3rd quarter worth $115,000. Finally, Millennium Management LLC bought a new stake in Senestech during the third quarter valued at about $126,000. Hedge funds and other institutional investors own 5.19% of the company’s stock.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.